- Home
- ASND vs HST Comparison
ASND vs HST Comparison
Compare ASND & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- HST
- Stock Information
- Founded
- ASND 2006
- HST 1927
- Country
- ASND Denmark
- HST United States
- Employees
- ASND N/A
- HST N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- HST Real Estate Investment Trusts
- Sector
- ASND Health Care
- HST Real Estate
- Exchange
- ASND Nasdaq
- HST Nasdaq
- Market Cap
- ASND 12.0B
- HST 10.0B
- IPO Year
- ASND 2015
- HST N/A
- Fundamental
- Price
- ASND $204.05
- HST $16.91
- Analyst Decision
- ASND Strong Buy
- HST Buy
- Analyst Count
- ASND 16
- HST 13
- Target Price
- ASND $240.75
- HST $18.04
- AVG Volume (30 Days)
- ASND 401.5K
- HST 8.9M
- Earning Date
- ASND 11-13-2025
- HST 11-05-2025
- Dividend Yield
- ASND N/A
- HST 5.32%
- EPS Growth
- ASND N/A
- HST N/A
- EPS
- ASND N/A
- HST 0.94
- Revenue
- ASND $576,332,355.00
- HST $5,938,000,000.00
- Revenue This Year
- ASND $102.31
- HST $5.78
- Revenue Next Year
- ASND $76.44
- HST $1.68
- P/E Ratio
- ASND N/A
- HST $18.04
- Revenue Growth
- ASND 54.50
- HST 8.38
- 52 Week Low
- ASND $118.03
- HST $12.22
- 52 Week High
- ASND $208.16
- HST $19.37
- Technical
- Relative Strength Index (RSI)
- ASND 60.82
- HST 43.80
- Support Level
- ASND $187.25
- HST $16.86
- Resistance Level
- ASND $205.48
- HST $17.66
- Average True Range (ATR)
- ASND 5.42
- HST 0.33
- MACD
- ASND 0.41
- HST -0.11
- Stochastic Oscillator
- ASND 92.16
- HST 4.81
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.